Shilpa Medicare Reports Significant Growth in Profit After Tax for May 2025
Shilpa Medicare has announced its financial results for the quarter ending March 2025, revealing a significant increase in Profit After Tax (PAT) to Rs 41.17 crore, up 98.8% from the previous four quarters. Profit Before Tax (PBT) also rose to Rs 35.78 crore, reflecting a 29.4% growth.
Shilpa Medicare, a midcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending March 2025. The results, declared on May 26, 2025, indicate a notable shift in the company's evaluation, with its score adjusting to 17 from 32 over the past three months.The financial data reveals a significant growth in Profit After Tax (PAT), which reached Rs 41.17 crore, marking a substantial increase of 98.8% compared to the average PAT of Rs 20.72 crore from the previous four quarters. This performance highlights a strong near-term trend for PAT, as it represents the highest figure recorded in the last five quarters.
Additionally, Profit Before Tax (PBT), excluding other income, also showed positive movement, amounting to Rs 35.78 crore, reflecting a growth of 29.4% against the average PBT of Rs 27.64 crore from the previous four quarters. This trend further underscores the favorable near-term outlook for Shilpa Medicare's financial performance.
For those interested in exploring more about Shilpa Medicare's financial trends and evaluations, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
